Literature DB >> 35851442

New Chemical Biology Tools for the Histamine Receptor Family.

Yang Zheng1, Gábor Wágner1, Niels Hauwert1, Xiaoyuan Ma1, Henry F Vischer1, Rob Leurs2.   

Abstract

The histamine research community has in the last decade been very active and generated a number of exciting new chemical biology tools for the study of histamine receptors, their ligands, and their pharmacology. In this paper we describe the development of histamine receptor structural biology, the use of receptor conformational biosensors, and the development of new ligands for covalent or fluorescent labeling or for photopharmacological approaches (photocaging and photoswitching). These new tools allow new approaches to study histamine receptors and hopefully will lead to better insights in the molecular aspects of histamine receptors and their ligands.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Biosensors; Covalent ligands; Fluorescent ligands; Histamine receptor structural biology; Photocaging; Photopharmacology; Photoswitching

Mesh:

Substances:

Year:  2022        PMID: 35851442     DOI: 10.1007/7854_2022_360

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  76 in total

Review 1.  Development of photolabile protecting groups and their application to the optochemical control of cell signaling.

Authors:  Anirban Bardhan; Alexander Deiters
Journal:  Curr Opin Struct Biol       Date:  2019-05-25       Impact factor: 6.809

2.  Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities.

Authors:  Michael Amon; Xavier Ligneau; Jean-Charles Schwartz; Holger Stark
Journal:  Bioorg Med Chem Lett       Date:  2006-01-24       Impact factor: 2.823

Review 3.  Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies.

Authors:  Renato A Bauer
Journal:  Drug Discov Today       Date:  2015-05-19       Impact factor: 7.851

Review 4.  Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.

Authors:  Yuemin Bian; Jaden Jungho Jun; Jacob Cuyler; Xiang-Qun Xie
Journal:  Eur J Med Chem       Date:  2020-08-09       Impact factor: 6.514

5.  A roadmap to success in photopharmacology.

Authors:  Johannes Broichhagen; James Allen Frank; Dirk Trauner
Journal:  Acc Chem Res       Date:  2015-06-23       Impact factor: 22.384

6.  BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.

Authors:  Reggie Bosma; Ryo Moritani; Rob Leurs; Henry F Vischer
Journal:  Pharmacol Res       Date:  2016-07-26       Impact factor: 7.658

7.  Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.

Authors:  Michael Amon; Xavier Ligneau; Jean-Claude Camelin; Isabelle Berrebi-Bertrand; Jean-Charles Schwartz; Holger Stark
Journal:  ChemMedChem       Date:  2007-05       Impact factor: 3.466

8.  The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor.

Authors:  Reggie Bosma; Jelle van den Bor; Henry F Vischer; Luis Labeaga; Rob Leurs
Journal:  Eur J Pharmacol       Date:  2018-09-07       Impact factor: 4.432

9.  A road map for prioritizing warheads for cysteine targeting covalent inhibitors.

Authors:  Péter Ábrányi-Balogh; László Petri; Tímea Imre; Péter Szijj; Andrea Scarpino; Martina Hrast; Ana Mitrović; Urša Pečar Fonovič; Krisztina Németh; Hélène Barreteau; David I Roper; Kata Horváti; György G Ferenczy; Janko Kos; Janez Ilaš; Stanislav Gobec; György M Keserű
Journal:  Eur J Med Chem       Date:  2018-10-06       Impact factor: 6.514

10.  Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.

Authors:  Reggie Bosma; Leigh A Stoddart; Victoria Georgi; Monica Bouzo-Lorenzo; Nick Bushby; Loretta Inkoom; Michael J Waring; Stephen J Briddon; Henry F Vischer; Robert J Sheppard; Amaury Fernández-Montalván; Stephen J Hill; Rob Leurs
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.